Skip to main content
. 2021 Oct 23;12(12):3079–3092. doi: 10.1007/s13300-021-01166-z

Table 2.

Treatment effects

Flash monitoring SMBG/POCT
Patients with T1D
 Physiological parameters
  Change from baseline HbA1c at the end of year 1 (%) 0.15 0.17
 Acute event rates (per 100 patient years)
  NSHE 2634 3550
  SHE1 35.7 79.4
  SHE2 13.8 30.6
  Ketoacidosis 1.0 1.4
Patients with T2D
 Physiological parameters
  Change from baseline HbA1c at the end of year 1 (%) − 0.3 − 0.3
 Acute event rates (per 100 patient years)
  NSHE 1685 2331
  SHE1 43.9 92.6
  SHE2 5.9 12.4

SMBG/POCT self-monitoring of blood glucose/point of care testing, T1D type 1 diabetes, T2D type 2 diabetes, NSHE non-severe hypoglycemia event, SHE1 severe hypoglycemia event grade 1 (requiring non-medical assistance), SHE2 severe hypoglycemia event grade 2 (requiring medical assistance), HbA1c glycated hemoglobin